ADCT R&D Expenses
Adc Therapeutics Sa · R&D Expenses
ADCT R&D Expenses
Latest reported$82.23Mperiod ending
ADCT TTM R&D Expenses ($118.31M → $82.23M)
TTM R&D Expenses
High-resolution chart · PNG
ADCT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 82,230,000 | |
| 94,954,000 | |
| 104,005,000 | |
| 112,922,000 | |
| 118,621,000 | |
| 112,826,000 | |
| 109,633,000 | |
| 112,862,000 | |
| 108,800,000 | |
| 115,847,000 | |
| 128,487,000 | |
| 146,890,000 | |
| 160,126,000 | |
| 177,321,000 | |
| 187,898,000 | |
| 181,657,000 | |
| 176,786,000 | |
| 167,782,000 | |
| 158,002,000 | |
| 164,062,000 | |
| 159,412,000 | |
| 145,829,000 | |
| 142,032,000 | |
| 123,904,000 | |
| 122,290,000 | |
| 118,100,000 | |
| 106,011,000 | |
| 104,677,000 | |
| 103,226,000 | |
| 111,532,500 | |
| 118,313,000 |